2.80
price down icon0.36%   -0.01
 
loading
前日終値:
$2.81
開ける:
$2.848
24時間の取引高:
14,687
Relative Volume:
0.81
時価総額:
$28.43M
収益:
-
当期純損益:
$-23.87M
株価収益率:
-0.1423
EPS:
-19.67
ネットキャッシュフロー:
$-47.63M
1週間 パフォーマンス:
+2.00%
1か月 パフォーマンス:
+1.82%
6か月 パフォーマンス:
-21.02%
1年 パフォーマンス:
-39.85%
1日の値動き範囲:
Value
$2.78
$2.848
1週間の範囲:
Value
$2.6804
$3.28
52週間の値動き範囲:
Value
$2.30
$4.67

Polypid Ltd Stock (PYPD) Company Profile

Name
名前
Polypid Ltd
Name
セクター
Healthcare (1178)
Name
電話
-
Name
住所
-
Name
職員
61
Name
Twitter
Name
次回の収益日
2024-11-13
Name
最新のSEC提出書
Name
PYPD's Discussions on Twitter

PYPD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PYPD
Polypid Ltd
2.79 29.04M 0 -23.87M -47.63M -19.67
Biotechnology icon
ONC
Beigene Ltd Adr
240.49 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.58 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.26 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
583.73 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
72.59 5.92B 0 -153.72M -103.81M -2.00

Polypid Ltd Stock (PYPD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-28 開始されました Rodman & Renshaw Buy
2021-09-14 開始されました JMP Securities Mkt Outperform
2021-07-30 開始されました Cantor Fitzgerald Overweight
2020-11-24 アップグレード Raymond James Outperform → Strong Buy
2020-08-10 開始されました Alliance Global Partners Buy
2020-07-21 開始されました BMO Capital Markets Outperform
2020-07-21 開始されました Barclays Overweight
2020-07-21 開始されました Raymond James Outperform
すべてを表示

Polypid Ltd (PYPD) 最新ニュース

pulisher
May 21, 2025

PolyPid chairman to step down at June shareholder meeting By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 21, 2025

PolyPid chairman to step down at June shareholder meeting - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

PolyPid Announces Leadership Changes Ahead of June 2025 Shareholder Meeting - TipRanks

May 21, 2025
pulisher
May 20, 2025

PolyPid Opens Virtual Access to Investors: Key Presentation and 1-on-1 Meetings at Lytham Conference - Stock Titan

May 20, 2025
pulisher
May 20, 2025

PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 - GlobeNewswire

May 20, 2025
pulisher
May 19, 2025

Head to Head Survey: PolyPid (NASDAQ:PYPD) & Lombard Medical (OTCMKTS:EVARF) - Defense World

May 19, 2025
pulisher
May 17, 2025

Tenon Medical (NASDAQ:TNON) vs. PolyPid (NASDAQ:PYPD) Critical Comparison - Defense World

May 17, 2025
pulisher
May 15, 2025

PolyPid Ltd. Earnings Call: Progress and Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

PolyPid Ltd. (NASDAQ:PYPD) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

PolyPid Ltd. Reports Q1 2025 Results and Trial Progress - TipRanks

May 15, 2025
pulisher
May 14, 2025

Polypid Q1 Net Income USD -8.3 Million - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

PolyPid (PYPD) Prepares for Transformational 2025 with Promising - GuruFocus

May 14, 2025
pulisher
May 14, 2025

PolyPid Completes Enrollment in Phase 3 Trial of D-PLEX100 - TipRanks

May 14, 2025
pulisher
May 14, 2025

PolyPid Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Transcript : PolyPid Ltd., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

PolyPid (PYPD) Expected to Announce Earnings on Wednesday - Defense World

May 13, 2025
pulisher
May 01, 2025

PolyPid Ltd. (NASDAQ:PYPD) Short Interest Update - Defense World

May 01, 2025
pulisher
Apr 29, 2025

PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025 - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

PolyPid Q1 2025 Earnings Preview: Surgical Outcomes Biopharma Reports May 14 - Stock Titan

Apr 29, 2025
pulisher
Apr 23, 2025

Reviewing Baxter International (NYSE:BAX) and PolyPid (NASDAQ:PYPD) - Defense World

Apr 23, 2025
pulisher
Apr 22, 2025

PolyPid to Participate in The Citizens Life Sciences Conference - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

PolyPid to Reveal Next-Gen Surgical Innovation Pipeline at Elite Citizens Life Sciences Conference - Stock Titan

Apr 22, 2025
pulisher
Apr 19, 2025

Short Interest in PolyPid Ltd. (NASDAQ:PYPD) Declines By 25.9% - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

What is HC Wainwright’s Estimate for PolyPid Q1 Earnings? - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

What is HC Wainwright’s Forecast for PolyPid Q1 Earnings? - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

H.C. Wainwright maintains Buy on PolyPid stock with $11 target - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

PolyPid’s (PYPD) Buy Rating Reaffirmed at HC Wainwright - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

H.C. Wainwright maintains Buy on PolyPid stock with $11 target By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 07, 2025

PolyPid stock touches 52-week low at $2.32 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

PolyPid stock touches 52-week low at $2.32 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 03, 2025

Surgical Site Infections Clinical and Non-Clinical Studies, - openPR.com

Apr 03, 2025
pulisher
Mar 24, 2025

Barclays Reaffirms Their Hold Rating on PolyPid (PYPD) - The Globe and Mail

Mar 24, 2025
pulisher
Mar 23, 2025

Comparing Beta Bionics (NASDAQ:BBNX) and PolyPid (NASDAQ:PYPD) - Defense World

Mar 23, 2025
pulisher
Mar 11, 2025

PolyPid Completes Enrollment in Phase 3 Trial for Surgical Infection Prevention - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

PolyPid Announces Successful Completion of Enrollment in - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

PolyPid Announces Successful Completion Of Enrollment In Phase 3 Shield II Trial Of D-Plex100 For The Prevention Of Abdominal Colorectal Surgical Site Infections - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections - Yahoo

Mar 11, 2025
pulisher
Mar 10, 2025

Critical Survey: Nyxoah (NASDAQ:NYXH) vs. PolyPid (NASDAQ:PYPD) - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

PolyPid (NASDAQ:PYPD) Stock Price Up 0.7% – Should You Buy? - Defense World

Mar 06, 2025
pulisher
Mar 03, 2025

PolyPid to Participate in the 37th Annual ROTH Conference - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

PolyPid Fireside Chat at ROTH Conference: What New Surgical Innovations Will Management Reveal? - StockTitan

Mar 03, 2025
pulisher
Feb 27, 2025

Polypid Ltd to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Polypid Ltd (PYPD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.225
price down icon 12.23%
$31.50
price down icon 3.35%
$578.71
price down icon 0.54%
$4.10
price down icon 2.24%
$287.65
price down icon 0.87%
$72.94
price down icon 0.11%
大文字化:     |  ボリューム (24 時間):